Scientific research on human insulin was a crucial development in medicine, and its discovery led to the treatment of diabetes, one of the most prevalent global chronic diseases. A seminal work published in 1979 describing recombinant DNA technology to produce human insulin through biocatalysis has resulted in this field’s establishment and routine industrial applications.
References
Sims, E. K. et al. Nat. Med. 27, 1154–1164 (2021).
Mayer, J. P., Zhang, F. & DiMarchi, R. D. Pept. Sci. 88, 687–713 (2007).
Banting, F. G., Best, C. H., Collip, J. B., Campbell, W. R. & Fletcher, A. A. Can. Med. Assoc. J. 12, 141–146 (1922).
de Leiva, A., Brugués, E. & de Leiva-Pérez, A. Endocrinol. Nutr. 58, 449–456 (2011).
Goeddel, D. V. et al. Proc. Natl Acad. Sci. USA 76, 106–110 (1979).
Kesavadev, J. et al. Diabetes Ther. 11, 1251–1269 (2020).
Moroder, L. & Musiol, H. J. Angew. Chem. Int. Ed. 56, 10656–10669 (2017).
Hancock, W. S. (ed.) High Performance Liquid Chromatography in Biotechnology (Wiley-Interscience, 1990).
Siew, Y. Y. & Zhang, W. Bioresour. Bioprocess. 8, 65 (2021).
Govender, K. et al. AMB Express 10, 43 (2020).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Govender, T., Naicker, T. Insulin as a catalyst to recombinant DNA technology. Nat Catal 6, 454–455 (2023). https://doi.org/10.1038/s41929-023-00976-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41929-023-00976-7
- Springer Nature Limited